Randomised study with docetaxel, cisplatin and cyclophosphamide vs docetaxel and carboplatin as first line chemotherapy with advanced or metastatic ovarian cancer

Trial Profile

Randomised study with docetaxel, cisplatin and cyclophosphamide vs docetaxel and carboplatin as first line chemotherapy with advanced or metastatic ovarian cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Aug 2012

At a glance

  • Drugs Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel
  • Indications Ovarian cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms OCSTUD
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Jun 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top